Oncolytics Biotech (TSE:ONC) Share Price Crosses Above 200 Day Moving Average – What’s Next?

Oncolytics Biotech Inc. (TSE:ONC)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$1.40 and traded as high as C$1.42. Oncolytics Biotech shares last traded at C$1.41, with a volume of 199,488 shares changing hands.

Analyst Ratings Changes

Separately, Raymond James upgraded Oncolytics Biotech to a “moderate buy” rating in a report on Thursday, November 14th.

Oncolytics Biotech Price Performance

The firm has a market cap of C$108.37 million, a P/E ratio of -3.71 and a beta of 1.35. The company has a debt-to-equity ratio of 6.09, a current ratio of 4.99 and a quick ratio of 8.86. The firm’s 50 day moving average is C$1.43 and its 200 day moving average is C$1.40.

Oncolytics Biotech Company Profile

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.